Global Implantable Cardioverter Defibrillators (ICD) Market 2018-2022

The global implantable cardioverter defibrillators (ICD) market size will grow by USD 496 million during 2018-2022. This report offers an analysis of the market based on product (regular ICD, CRT-D, and subcutaneous-ICD), end-user (hospitals and clinics and ambulatory surgery centers), and geography (the Americas, APAC, and EMEA). The implantable cardioverter defibrillators (ICD) market research report analyzes the market’s competitive landscape and offers information on several companies including Abbott, BIOTRONIK, Boston Scientific, and Medtronic.

Below are some of the key findings from the implantable cardioverter defibrillators (ICD) market research report:

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Get a FREE sample now!

Global implantable cardioverter defibrillators (ICD) industry overview

Globally, there has been an alarming increase in the prevalence of cardiac arrhythmias.  This can be attributed to several factors such as growing geriatric population, and other associated risk factors of CVDs such as smoking, obesity, blood pressure, and alcohol consumption. Therefore, the rising prevalence of cardiac arrhythmias will increase the demand for cardiac implants, which will fuel the growth of the ICD market during the forecast period. The number of ICD interventions has significantly increased in the recent decade due to the proven efficacy of these devices in preventing SCDs in selected populations.

Technological advances will be one of the key trends that will positively impact the ICD market during the forecast period. Technological advances such as the development of MRI safe ICDs, improvements in patient monitoring to avoid needless shocks, and the introduction of quadripolar lead devices have significantly improved the reliability and effectiveness of ICDs. Further, vendors are introducing advanced features in their ICDs to reduce the incidence of shocks. For instance, Medtronic's Evera MRI ICD is equipped with SmartShock 2.0, a shock reduction algorithm that enables the device to differentiate between dangerous and harmless heart rhythms accurately. Such advances in technology will boost the demand for ICDs during the forecast period.

Top implantable cardioverter defibrillators (ICD) companies covered in this market research report

The implantable cardioverter defibrillators (ICD) market is highly concentrated. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this implantable cardioverter defibrillator (ICD) industry analysis report will aid clients identify and design new growth strategies.

The report offers a complete analysis of various companies including:

• Abbott
• BIOTRONIK
• Boston Scientific
• Medtronic

Implantable cardioverter defibrillators (ICD) market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the companies, the Americas will account for the highest ICD market share throughout the forecast period. This can be attributed to several factors such as access to advanced ICDs, the high prevalence of cardiac arrhythmias and its related risk factors and awareness about technologically advanced ICDs.

Implantable cardioverter defibrillators (ICD) market segmentation based on product

• Regular ICD
• Cardiac resynchronization therapy defibrillators (CRT-D)
• Subcutaneous-ICD (S-ICD)

The regular ICD segment will account for the largest share of the ICD market. Additionally, the report also provides an accurate prediction of the contribution of all the various products segments to the growth of the implantable cardioverter defibrillators (ICD) market size.

Key highlights of the global implantable cardioverter defibrillators (ICD) market for the forecast years 2018-2022:

• CAGR of the market during the forecast period 2018-2022
• Detailed information on factors that will accelerate the growth of the implantable cardioverter defibrillators (ICD) market during the next five years
• Precise estimation of the global implantable cardioverter defibrillators (ICD) market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• Growth of the implantable cardioverter defibrillators (ICD) industry across the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on the factors that will challenge the growth of implantable cardioverter defibrillators (ICD) companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch